SlowBull
The Business Brief SATURDAY, 8 AUGUST 2026
← All stories
Markets

Oppenheimer reiterates Compass Pathways stock rating on FDA progress

1 source ·2 articles ·Aug 5, 19:06 UTC Oppenheimer COMPASS Pathways Compass

Covered by 1 outlet

Investing 2

All coverage · 2 articles

Investing.com Canada ·Aug 5, 19:06 UTC

Oppenheimer reiterates Compass Pathways stock rating on FDA progress

Investing.com UK ·Aug 5, 19:06 UTC

Oppenheimer reiterates Compass Pathways stock rating on FDA progress